AGT and metabolic dysfunction-associated steatohepatitis: Angiotensin II may promote hepatic steatosis and inflammation by increasing reactive oxygen species (ROS) following stimulation of angiotensin II receptors in animal NASH models (Hirose et al., 2007; Nabeshima et al., 2009).